Pharma Mar (XMAD:PHM) EV-to-Revenue : 2.86 (As of May. 12, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Pharma Mar's enterprise value is €463.6 Mil. Pharma Mar's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €162.1 Mil. Therefore, Pharma Mar's EV-to-Revenue for today is 2.86.

The historical rank and industry rank for Pharma Mar's EV-to-Revenue or its related term are showing as below:

XMAD:PHM' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.1 Med: 4.26 Max: 13.32
Current: 2.86

During the past 13 years, the highest EV-to-Revenue of Pharma Mar was 13.32. The lowest was 2.10. And the median was 4.26.

XMAD:PHM's EV-to-Revenue is ranked better than
74.11% of 1039 companies
in the Biotechnology industry
Industry Median: 8.37 vs XMAD:PHM: 2.86

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Pharma Mar's stock price is €33.30. Pharma Mar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €9.14. Therefore, Pharma Mar's PS Ratio for today is 3.64.

Pharma Mar EV-to-Revenue Historical Data

The historical data trend for Pharma Mar's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar EV-to-Revenue Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

9.95

4.25

3.80

5.22

3.83

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															3.70	2.32	2.62	3.83	2.37

Competitive Comparison of Pharma Mar's EV-to-Revenue

For the Biotechnology subindustry, Pharma Mar's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharma Mar's EV-to-Revenue falls into.

Pharma Mar EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Pharma Mar's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	463.553	/	162.14
	=	2.86

Pharma Mar's current Enterprise Value is €463.6 Mil.
Pharma Mar's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €162.1 Mil.

Pharma Mar (XMAD:PHM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Pharma Mar's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	33.30	/	9.14
	=	3.64

Pharma Mar's share price for today is €33.30.
Pharma Mar's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.14.

Pharma Mar EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharma Mar's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.